Damon Young - Publications

University of Michigan, Ann Arbor, Ann Arbor, MI 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Young D, Popiolek M, Trapa P, Fonseca KR, Brevard J, Gray DL, Kozak R. D1 agonist improved movement of parkinsonian nonhuman primates with limited dyskinesia side effects. Acs Chemical Neuroscience. PMID 31971364 DOI: 10.1021/acschemneuro.9b00589  1
2018 Popiolek M, Mandelblat-Cerf Y, Young D, Garst-Orozco J, Lotarski SM, Stark E, Kramer M, Butler CR, Kozak R. In vivo modulation of hippocampal excitability by M4 muscarinic acetylcholine receptor activator: implications for treatment of Alzheimer's disease and schizophrenic patients. Acs Chemical Neuroscience. PMID 30335349 DOI: 10.1021/acschemneuro.8b00496  1
2018 Howe WM, Brooks JL, Tierney PL, Pang J, Rossi A, Young D, Dlugolenski K, Guillmette E, Roy M, Hales K, Kozak R. α5 nAChR modulation of the prefrontal cortex makes attention resilient. Brain Structure & Function. PMID 29299690 DOI: 10.1007/s00429-017-1601-1  1
2016 Howe WM, Young DA, Bekheet G, Kozak R. Nicotinic receptor subtypes differentially modulate glutamate release in the dorsal medial striatum. Neurochemistry International. PMID 27568861 DOI: 10.1016/j.neuint.2016.08.009  1
2015 Mohler EG, Ding Z, Rueter LE, Chapin D, Young D, Kozak R. Cross-site strain comparison of pharmacological deficits in the touchscreen visual discrimination test. Psychopharmacology. PMID 26177580 DOI: 10.1007/s00213-015-4012-0  0.6
2015 Howe WM, Tierney PL, Young DA, Oomen C, Kozak R. MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function. Psychopharmacology. PMID 25963563 DOI: 10.1007/s00213-015-3955-5  0.6
2014 Kozak R, Campbell BM, Strick CA, Horner W, Hoffmann WE, Kiss T, Chapin DS, McGinnis D, Abbott AL, Roberts BM, Fonseca K, Guanowsky V, Young DA, Seymour PA, Dounay A, et al. Reduction of brain kynurenic acid improves cognitive function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 10592-602. PMID 25100593 DOI: 10.1523/JNEUROSCI.1107-14.2014  0.76
2014 Koshy Cherian A, Gritton H, Johnson DE, Young D, Kozak R, Sarter M. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats. Neuropharmacology. 82: 41-8. PMID 24647121 DOI: 10.1016/j.neuropharm.2014.03.004  0.76
2007 Briand LA, Gritton H, Howe WM, Young DA, Sarter M. Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Progress in Neurobiology. 83: 69-91. PMID 17681661 DOI: 10.1016/j.pneurobio.2007.06.007  0.76
2007 Kozak R, Martinez V, Young D, Brown H, Bruno JP, Sarter M. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2074-86. PMID 17299502 DOI: 10.1038/sj.npp.1301352  0.76
Show low-probability matches.